MERSALYL-THEOPHYLLINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mersalyl-theophylline, and when can generic versions of Mersalyl-theophylline launch?
Mersalyl-theophylline is a drug marketed by Watson Labs and is included in one NDA.
The generic ingredient in MERSALYL-THEOPHYLLINE is mersalyl sodium; theophylline. Additional details are available on the mersalyl sodium; theophylline profile page.
Summary for MERSALYL-THEOPHYLLINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MERSALYL-THEOPHYLLINE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for MERSALYL-THEOPHYLLINE
US Patents and Regulatory Information for MERSALYL-THEOPHYLLINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | MERSALYL-THEOPHYLLINE | mersalyl sodium; theophylline | INJECTABLE;INJECTION | 084875-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |